Melanoma clinicopathological groups characterized and compared with dermoscopy and reflectance confocal microscopy - 11/01/24
Abstract |
Background |
Dermoscopic and reflectance confocal microscopy (RCM) correlations between morphologic groups of melanoma have not yet been described.
Objective |
Describe and compare dermoscopic and RCM features of cutaneous melanomas with histopathological confirmation.
Methods |
Single center, retrospective analysis of consecutive melanomas evaluated with RCM (2015-2019). Lesions were clinically classified as typical, nevus-like, amelanotic/nonmelanoma skin cancer (NMSC)-like, seborrheic keratosis (SK)-like and lentigo/lentigo maligna (LM)-like. Presence or absence of common facial and nonfacial melanoma dermoscopic and RCM patterns were recorded. Clusters were compared with typical lesions by multivariate logistic regression.
Results |
Among 583 melanoma lesions, significant differences between clusters were evident (compared to typical lesions). Observation of dermoscopic features (>50% of lesions) in amelanotic/NMSC-like lesions consistently displayed 3 patterns (atypical network, atypical vascular pattern + regression structures), and nevus-like and SK-like lesions and lentigo/LM-like lesions consistently displayed 2 patterns (atypical network + regression structures, and nonevident follicles + heavy pigmentation intensity). Differences were less evident with RCM, as almost all lesions were consistent with melanoma diagnosis.
Limitations |
Small SK-like lesions sample, single RCM analyses (no reproduction of outcome).
Conclusion |
RCM has the potential to augment our ability to consistently and accurately diagnose melanoma independently of clinical and dermoscopic features.
Le texte complet de cet article est disponible en PDF.Key words : dermoscopy, histology, histopathology, melanoma, melanoma features, RCM, reflectance confocal microscopy
Abbreviations used : BCC, DEJ, LM, LMM, NMSC, RCM, SK
Plan
| Funding sources: The research leading to these results has received funding from the European Union - NextGenerationEU through the Italian Ministry of University and Research under PNRR - M4C2-I1.3 Project PE_00000019 HEAL ITALIA to Francesca Farnetani CUP E93C22001860006. |
|
| Disclaimer: The views and opinions expressed are those of the authors only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: IRB of University of Modena and Reggio Emilia approved the study. Protocol number 0008852/20. |
Vol 90 - N° 2
P. 309-318 - février 2024 Retour au numéro
Article précédent
- JAAD Game Changer: Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion
- Wendi E. Wohltmann
- More than just methylisothiazolinone: Retrospective analysis of patients with isothiazolinone allergy in North America, 2017-2020
- Margo J. Reeder, Donglin Zhang, Srikanth R. Aravamuthan, Erin M. Warshaw, Joel G. DeKoven, Jonathan I. Silverberg, Brandon L. Adler, Amber R. Atwater, James S. Taylor, Marie-Claude Houle, Donald V. Belsito, Jiade Yu, Nina Botto, Christen M. Mowad, Cory A. Dunnick, Vincent A. DeLeo, Melanie D. Pratt
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?